Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes

Context: Tranexamic acid is commonly used for curing abnormal bleeding in a variety of diseases. In a previous study, 12 different tetrahydro-2H-1,3,5-thiadiazine derivatives were synthesized from the amine group of tranexamic acid. Their antifibrinolytic and antimicrobial activities were compared w...

Full description

Bibliographic Details
Main Authors: Ece Avuloğlu-Yılmaz, Deniz Yüzbaşıoğlu, Azime Berna Özçelik, Seyhan Ersan, Fatma Ünal
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Pharmaceutical Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/13880209.2017.1296000
id doaj-6240af07704d45bc800639790c1ef803
record_format Article
spelling doaj-6240af07704d45bc800639790c1ef8032020-11-25T03:48:26ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162017-01-015511228123310.1080/13880209.2017.12960001296000Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytesEce Avuloğlu-Yılmaz0Deniz Yüzbaşıoğlu1Azime Berna Özçelik2Seyhan Ersan3Fatma Ünal4Gazi UniversityGazi UniversityGazi UniversityGazi UniversityGazi UniversityContext: Tranexamic acid is commonly used for curing abnormal bleeding in a variety of diseases. In a previous study, 12 different tetrahydro-2H-1,3,5-thiadiazine derivatives were synthesized from the amine group of tranexamic acid. Their antifibrinolytic and antimicrobial activities were compared with tranexamic acid. 3-Methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (3-MTTT) was the most remarkable one, which may be used as a drug. Objectives: In vitro genotoxicity of 3-MTTT was investigated using chromosome aberrations (CAs), sister chromatid exchanges (SCEs), micronucleus (MN) and comet assays. Materials and methods: Various concentrations 0.78, 1.56, 3.13, 6.25, 12.50 and 25.00 μg/mL of 3-MTTT were applied to lymphocytes obtained from two donors for periods of 24 and 48 h. A negative (distilled water), a solvent (2:1 PBS:10% NaOH for cultured lymphocyte, and PBS for isolated lymphocytes) and a positive control (MMC for cultured lymphocytes and H2O2 for isolated lymphocytes) were also maintained. Results: While this compound did not increase the frequency of abnormal cells and CA/cell ratio compared to negative control (except 48 h, 25 μg/mL), it significantly increased the frequency of SCEs at the four highest concentrations at both treatment periods (except 6.25 μg/mL, 48 h). It significantly decreased the MI in all the concentrations at 24 h (except 0.78 μg/mL) and in the highest three concentrations at 48 h. This compound did not significantly increase the frequency of MN and DNA damage compared to negative control. This compound did not affect the replication and nuclear division index. Discussion and conclusion: Our results demonstrated that this compound does not represent a significant risk at the genetic level in in vitro human lymphocytes.http://dx.doi.org/10.1080/13880209.2017.1296000tranexamic acidgenotoxicitydna damagelymhocyte culture
collection DOAJ
language English
format Article
sources DOAJ
author Ece Avuloğlu-Yılmaz
Deniz Yüzbaşıoğlu
Azime Berna Özçelik
Seyhan Ersan
Fatma Ünal
spellingShingle Ece Avuloğlu-Yılmaz
Deniz Yüzbaşıoğlu
Azime Berna Özçelik
Seyhan Ersan
Fatma Ünal
Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
Pharmaceutical Biology
tranexamic acid
genotoxicity
dna damage
lymhocyte culture
author_facet Ece Avuloğlu-Yılmaz
Deniz Yüzbaşıoğlu
Azime Berna Özçelik
Seyhan Ersan
Fatma Ünal
author_sort Ece Avuloğlu-Yılmaz
title Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
title_short Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
title_full Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
title_fullStr Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
title_full_unstemmed Evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
title_sort evaluation of genotoxic effects of 3-methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2h-1,3,5-thiadiazine-2-thione on human peripheral lymphocytes
publisher Taylor & Francis Group
series Pharmaceutical Biology
issn 1388-0209
1744-5116
publishDate 2017-01-01
description Context: Tranexamic acid is commonly used for curing abnormal bleeding in a variety of diseases. In a previous study, 12 different tetrahydro-2H-1,3,5-thiadiazine derivatives were synthesized from the amine group of tranexamic acid. Their antifibrinolytic and antimicrobial activities were compared with tranexamic acid. 3-Methyl-5-(4-carboxycyclohexylmethyl)-tetrahydro-2H-1,3,5-thiadiazine-2-thione (3-MTTT) was the most remarkable one, which may be used as a drug. Objectives: In vitro genotoxicity of 3-MTTT was investigated using chromosome aberrations (CAs), sister chromatid exchanges (SCEs), micronucleus (MN) and comet assays. Materials and methods: Various concentrations 0.78, 1.56, 3.13, 6.25, 12.50 and 25.00 μg/mL of 3-MTTT were applied to lymphocytes obtained from two donors for periods of 24 and 48 h. A negative (distilled water), a solvent (2:1 PBS:10% NaOH for cultured lymphocyte, and PBS for isolated lymphocytes) and a positive control (MMC for cultured lymphocytes and H2O2 for isolated lymphocytes) were also maintained. Results: While this compound did not increase the frequency of abnormal cells and CA/cell ratio compared to negative control (except 48 h, 25 μg/mL), it significantly increased the frequency of SCEs at the four highest concentrations at both treatment periods (except 6.25 μg/mL, 48 h). It significantly decreased the MI in all the concentrations at 24 h (except 0.78 μg/mL) and in the highest three concentrations at 48 h. This compound did not significantly increase the frequency of MN and DNA damage compared to negative control. This compound did not affect the replication and nuclear division index. Discussion and conclusion: Our results demonstrated that this compound does not represent a significant risk at the genetic level in in vitro human lymphocytes.
topic tranexamic acid
genotoxicity
dna damage
lymhocyte culture
url http://dx.doi.org/10.1080/13880209.2017.1296000
work_keys_str_mv AT eceavulogluyılmaz evaluationofgenotoxiceffectsof3methyl54carboxycyclohexylmethyltetrahydro2h135thiadiazine2thioneonhumanperipherallymphocytes
AT denizyuzbasıoglu evaluationofgenotoxiceffectsof3methyl54carboxycyclohexylmethyltetrahydro2h135thiadiazine2thioneonhumanperipherallymphocytes
AT azimebernaozcelik evaluationofgenotoxiceffectsof3methyl54carboxycyclohexylmethyltetrahydro2h135thiadiazine2thioneonhumanperipherallymphocytes
AT seyhanersan evaluationofgenotoxiceffectsof3methyl54carboxycyclohexylmethyltetrahydro2h135thiadiazine2thioneonhumanperipherallymphocytes
AT fatmaunal evaluationofgenotoxiceffectsof3methyl54carboxycyclohexylmethyltetrahydro2h135thiadiazine2thioneonhumanperipherallymphocytes
_version_ 1724499091190185984